Acelrx announces rebranding with name change to talphera, inc.

Name change to "talphera" reflects a new era of the company in partnership with the medical community developing novel solutions for medically supervised settings talphera will begin trading on nasdaq under the trading symbol "tlph" effective  january 10 san mateo, calif. , jan. 9, 2024 /prnewswire/ -- acelrx pharmaceuticals, inc. (nasdaq: acrx), (acelrx), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced the rebranding of the company, with a name change to talphera, inc. ("talphera").
ACRX Ratings Summary
ACRX Quant Ranking